Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia
##plugins.themes.academic_pro.article.main##
Abstract
Aim: To evaluate the prognostic value of preoperative serum carcino-embryonic antigen (CEA) level in patients with colorectal cancer.
Methods: This retrospective study included 125 colorectal cancer patients aged from 14 to 87 years, surgically treated between January 2001 and December 2006. Preoperative serum CEA was measured by chemiluminescence assay.
Results: within the patients, 57 were males and 68 females. They have tumours classified Dukes A in 2 patients, B in 24 patients, C in 53 patients and Dukes D in 46 patients. Median follow-up period was 24 months (range, 4 - 72 months). The relapse-free survival was significantly higher in patients with CEA < 5 ng/ml compared to CEA ³ 5 ng/ml, (p < 0.0001). We observed significant differences in relapse-free survival between patients with CEA < 5 ng/ml and those with CEA ³ 5 ng/ml among patients classified as Dukes stage B (p=0.007) and C (p < 0.0001). However, there was no significant difference in relapse-free survival among those classified as Dukes stage D. Cox multivariate analysis demonstrated that preoperative serum CEA level was a significant independent prognostic factor for relapse-free survival (hazard ratio: 6.49, 95% CI, 3.09 to 13.62, p < 0.0001).
Conclusion: Preoperative serum CEA is a reliable predictor factor for recurrence in patients with CRC. CEA might be used in staging system and will be useful for therapeutic orientation in patients undergoing curative resection of CRC.
Methods: This retrospective study included 125 colorectal cancer patients aged from 14 to 87 years, surgically treated between January 2001 and December 2006. Preoperative serum CEA was measured by chemiluminescence assay.
Results: within the patients, 57 were males and 68 females. They have tumours classified Dukes A in 2 patients, B in 24 patients, C in 53 patients and Dukes D in 46 patients. Median follow-up period was 24 months (range, 4 - 72 months). The relapse-free survival was significantly higher in patients with CEA < 5 ng/ml compared to CEA ³ 5 ng/ml, (p < 0.0001). We observed significant differences in relapse-free survival between patients with CEA < 5 ng/ml and those with CEA ³ 5 ng/ml among patients classified as Dukes stage B (p=0.007) and C (p < 0.0001). However, there was no significant difference in relapse-free survival among those classified as Dukes stage D. Cox multivariate analysis demonstrated that preoperative serum CEA level was a significant independent prognostic factor for relapse-free survival (hazard ratio: 6.49, 95% CI, 3.09 to 13.62, p < 0.0001).
Conclusion: Preoperative serum CEA is a reliable predictor factor for recurrence in patients with CRC. CEA might be used in staging system and will be useful for therapeutic orientation in patients undergoing curative resection of CRC.
Keywords:
Carcino-embryonic antigen, colorectal cancer, prognostic factor##plugins.themes.academic_pro.article.details##
References
- Jantscheff P., Terracciano L., Lowy A., et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol 2003; 21: 3638-46.
- Berger AC., Sigurdson ER., LeVoyer T., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-12
- Liang H., Wang XN., Wang BG., et al. Prognostic factors of young patients with colon cancer after surgery. World J Gastroenterol 2006; 12: 1458-62.
- Turnbull RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation on the survival rates. Ann Surg. 1967; 166: 420-27.
- Wei-Shu wang, Jen-Kou lin, Tzeon-Jye Chiou, et al. Preoperative carcino-embryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan Experience. Jpn J Clin Oncol 2000; 30: 12-16.
- Elawady S., Lithy R., Morshed M., et al. Utility of serum preoperative carcino-embryonic antigen in colorectal cancer patient. Hepatogastroenterology 2009; 56:361-6.
- Lim YK., Kam MH., Eu K W. Carcino-embryonic antigen screening: how far should we go. Singapore Med J 2009; 50: 862-65.
- Bronstein BR., Steele Jr GD., Ensminger W, et al. The use and limitation of serial plasma carcino-embryonic antigen levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy. Cancer 1980; 46: 266-72
- Huh JW, Oh BR, Kim HR, Kim YJ. Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer. J Surg Oncol 2010; 101: 396-400.
- Goslin R., Steele G Jr., Macintyre J., et al. The use of preoperative plasma CEA levels for stratification of patients after curative resection of colorectal cancer. Ann Surg 1980;192: 747- 51.
- Lewi H., Blumgart LH., Carter DC., et al. Preoperative carcinoembryonic antigen and survival in patients with colorectal cancer. Br J surgery 1984; 71: 206-208.
- Chien-Chih Chen, Shung-Haur Yang, Jen-Kou Lin, et al. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer. J Surg Res 2005; 124:169-74.
- Ryo Takagawa, Syoichi Fujjii, Mitsuyoshi Ohta, et al. Preoperative serum carcino-embryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol 2008; 15: 3433- 39.
- Wang JY., Lu CY., Chu KS., et al. Prognostic significance of pre- and postoperative serum carcino-embryonic antigen levels in patients with colorectal cancer. Eur Surg Res 2007; 39: 245- 50.
- Srambu V., Iorga C., Radu P., et al. Prognostic factors in colorectal cancer evolution. RJME 2011; 52:373-377.
- Matthew R., Dixon MD., Jason S., et al. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 2003; 138: 962-966.